Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaye J Williams

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
BMC Systems Biology|October 25, 2013
A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructionsHelen L Kotze, Emily G Armitage, Kieran J Sharkey, et al.
The Journal of Gene Medicine|April 3, 2007
Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11)Torkjel Matzow, Rachel L Cowen, Kaye J Williams, et al.
Scientific Reports|April 27, 2022
A preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantomEmma R Biglin, Adam H Aitkenhead, Gareth J Price, et al.
Scientific Reports|October 6, 2020
3D DESI-MS lipid imaging in a xenograft model of glioblastoma: a proof of principleFiona Henderson, Emrys Jones, Joanna Denbigh, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 21, 2012
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitroRoben G Gieling, Catriona A Parker, Lisa A De Costa, et al.
Molecular Cancer Therapeutics|September 20, 2011
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in miceMajid Ali, Marzieh Kamjoo, Huw D Thomas, et al.
Molecular Pharmaceutics|April 24, 2019
Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44Alice Spadea, Julio Manuel Rios de la Rosa, Annalisa Tirella, et al.
Cancers|May 14, 2022
Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to TherapyPaul David Tar, Neil A Thacker, Muhammad Babur, et al.
EMBO Molecular Medicine|November 1, 2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironmentEmma J Searle, Brian A Telfer, Debayan Mukherjee, et al.
Theranostics|August 22, 2017
Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate CancerMichal R Tomaszewski, Isabel Quiros Gonzalez, James Pb O'Connor, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
BMC Systems Biology|October 25, 2013
A novel untargeted metabolomics correlation-based network analysis incorporating human metabolic reconstructionsHelen L Kotze, Emily G Armitage, Kieran J Sharkey, et al.
The Journal of Gene Medicine|April 3, 2007
Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11)Torkjel Matzow, Rachel L Cowen, Kaye J Williams, et al.
Scientific Reports|April 27, 2022
A preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantomEmma R Biglin, Adam H Aitkenhead, Gareth J Price, et al.
Scientific Reports|October 6, 2020
3D DESI-MS lipid imaging in a xenograft model of glioblastoma: a proof of principleFiona Henderson, Emrys Jones, Joanna Denbigh, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 21, 2012
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitroRoben G Gieling, Catriona A Parker, Lisa A De Costa, et al.
Molecular Cancer Therapeutics|September 20, 2011
The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in miceMajid Ali, Marzieh Kamjoo, Huw D Thomas, et al.
Molecular Pharmaceutics|April 24, 2019
Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44Alice Spadea, Julio Manuel Rios de la Rosa, Annalisa Tirella, et al.
Cancers|May 14, 2022
Habitat Imaging of Tumors Enables High Confidence Sub-Regional Assessment of Response to TherapyPaul David Tar, Neil A Thacker, Muhammad Babur, et al.
EMBO Molecular Medicine|November 1, 2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironmentEmma J Searle, Brian A Telfer, Debayan Mukherjee, et al.
Theranostics|August 22, 2017
Oxygen Enhanced Optoacoustic Tomography (OE-OT) Reveals Vascular Dynamics in Murine Models of Prostate CancerMichal R Tomaszewski, Isabel Quiros Gonzalez, James Pb O'Connor, et al.
Pageof 10